According to previous studies, and considering the potential role of ALDOA expression in the process of gluconeogenesis and glycolysis of tumor cells, we explored the potential correlation between ALDOA and AKT, another important upstream target of mTOR20–22. The gene discussed is AKT1; the disease is neoplasm.